|
1
|
Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.
|
Am J Pathol
|
2003
|
1.16
|
|
2
|
Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
|
Am J Pathol
|
2003
|
1.13
|
|
3
|
Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
|
J Neuropathol Exp Neurol
|
2004
|
0.97
|
|
4
|
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.
|
Exp Neurol
|
2007
|
0.95
|
|
5
|
A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
|
Exp Neurol
|
2005
|
0.88
|
|
6
|
Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy.
|
J Neuropathol Exp Neurol
|
2004
|
0.86
|
|
7
|
Sympathetic neuroaxonal dystrophy in the aged rat pineal gland.
|
Neurobiol Aging
|
2005
|
0.75
|